An X chromosome gene appears to drive inflammation in the brain, and may explain why women are more likely to develop MS, per ...

An MS relapse and the end of a relationship leave columnist Ahna Crum feeling unsafe and unsure about the world around her.

Liberate Bio’s CAR-M cell therapy almost completely depleted B-cells in a nonhuman primate study, the company said.

Jana Hlavacova, a Czech government employee who lives with MS, is helping shape policies in healthcare and the design of ...

Trageting abnormal brain cells linked to chronic inflammation may be key to treating people with progressive forms of MS, a ...

People with MS are more than twice as likely to experience headaches, including migraines, than their healthy counterparts, per a study.

Jill Blackburn, a pediatric MS mom, founded the Pediatric Multiple Sclerosis Alliance to help other families of kids with the ...

According to columnist Ben Hofmeister, MS forces him to become a jack-of-all-trades in managing symptoms and daily tasks. There are benefits.

EG110A received FDA fast track designation to treat neurogenic detrusor overactivity, a bladder issue common in MS.

The U.S. Food and Drug Administration (FDA) has given Tr1x the green light to launch a first-in-human clinical trial of TRX319, a cell therapy candidate designed to restore immune balance in people ...

Compassion means listening to your body without guilt and sometimes avoiding just "pushing through," writes columnist.